ESC in Asia

The ESC has developed collaborative relationships with its cardiac society partners in Asia to make a difference in the prevention, diagnosis and management of cardiovascular disease on a global scale. To do this, it is extremely important to:

• Exchange for a better understanding of the regional needs and to share the latest worldwide science for best practice to advance the battle against cardiovascular disease.
• Collaborate and strengthen the relationship between Asia Pacific cardiovascular professionals and the worldwide cardiovascular community by participating in one or more of the exciting events where the European Society of Cardiology will actively be present.

Scientific Programme

Friday 8 November

16:00 – 17:15 - Advances in cardiovascular surgery

Chairpersons:  Jimmy Hon, Singapore - Sivaraj Pillai Govindasamy, Singapore

Panelists: Victor Chao, Singapore - Yee-Jim Loh, Singapore - Andrew Yung-Tsai Lee, Taiwan

• What's new in the 2024 ESC Guidelines for the Management of Aortic Diseases? - Jose Fernando Rodriguez
• Palomares, Spain (ESC Virtual)
• CABG in end stage renal failure patients - Kenny Sin, Singapore
• TAVI in Asian patients: unique characteristics and alternative access - Andrew Yung-Tsai LEE, Taiwan
• TAVR durability and management of transcatheter aortic valve failure - Andrew Yung-Tsai LEE, Taiwan
• Panel discussion

Saturday 9 November

10:15 - 11:30 - Frontiers in atrial fibrillation management

Chairpersons: Michiel Rienstra, The Netherlands (ESC) - Chi-Keong Ching, Singapore

Panelists: Nwe Nwe, Myanmar - Erdie Fadreguilan, Philippines - Yoga Yuniadi, Indonesia

• What's new in the 2024 ESC Guidelines for the Management of Atrial Fibrillation? - Michiel Rienstra, The Netherlands (ESC)
• Reducing stroke risk in atrial fibrillation: anticoagulants or atrial appendage closure? - Khin Oo Lwin, Myanmar
• New technologies in atrial fibrillation ablation: which is the best? - Lin-Yee Chen, USA
• Panel discussion

11:30 – 12:45, Guidelines in Practice: 2024 ESC Guidelines for the Management of Chronic Coronary Syndromes

Chairpersons:  Emeline Van Craenenbroeck, Belgium (ESC) - Richard Ng, Singapore

Panelists: Ngoc Quang Nguyen, Vietnam - Alan Fong, Malaysia

• What's new in the 2024 ESC Guidelines for the Management of Chronic Coronary Syndromes? - Emeline Van Craenenbroeck, Belgium
• Medical versus invasive management of stable CAD - is the debate over? - Rodney Jimenez, Philippines
• Viability assessment before revascularisation for ischaemic cardiomyopathy - dead or alive? - Min-Sen Yew, Singapore
• INOCA - The not so innocuous syndrome - Adrian Low, Singapore
• Panel discussion

12:00 - 14:00 - Sponsored Lunch Symposium

14:00 – 15 :15 - Hot Lines from ESC Congress 2024 I (AF/HF)

Chairpersons: Teerapat Yingchoncharoenn, Thailand - Michiel Rienstra, The Netherlands (ESC)

Panelists : Michel Komajda, France (ESC) - Wee-Tiong Yeo, Singapore

• STOP-or-NOT - Impact of renin-angiotensin system inhibitors continuation versus discontinuation on postoperative complications: a multicenter randomised, controlled trial - Joshua Chung, Malaysia
• FINEARTS-HF - Finerenone in heart failure with mildly reduced and preserved ejection fraction - Carolyn Lam, Singapore
• OCEANIC-AF - Asundexian versus apixaban in patients with atrial fibrillation - Elaine Boey, Singapore
• GUARD-AF - ReducinG stroke by screening for UndiAgnosed atRial fibrillation in elderly inDividuals - Colin Yeo, Singapore
• Panel discussion

14:00 – 15 :15 -  Guidelines in Practice:  2024 ESC Guidelines for the Management of Elevated Blood Pressure and Hypertension

Chairpersons: Rosa Maria Bruno, France (ESC) - Long Doan, Vietnam

Panelists: Jimmy Boon-Wee Teo, Singapore - Anwar Santoso, Indonesia

• What's new in the 2024 ESC Guidelines for the Management of Elevated Blood Pressure and Hypertension? - Rosa Maria Bruno, France (ESC)
• Workup and medical management of resistant hypertension - case sharing  - Walid Amil, Philippines
• Renal denervation - Chee-Tang Chin, Singapore
• Panel discussion

15:15 – 15:45 - Coffee break

15:45 – 17:00, Hot Lines from ESC Congress 2024 II (CAD)

Chairpersons:  - Thomas Felix Luscher, UK (ESC Virtual) - Kia-Huat Lam, Malaysia

Panelists: Huay-Cheem Tan, Singapore - Emeline Van Craenenbroeck, Belgium (ESC) 

• Beta blocker interruption in patients with prior myocardial infarction: results of the ABYSS trial and effect on blood pressure and heart rate control - Antonio Anna Lukito, Indonesia
• ASSURE DES - Perioperative antiplatelet therapy in patients with coronary stents before non-cardiac surgery - Simon Lo, Malaysia
• SENIOR RITA - Invasive versus Conservative Strategy for Older Patients with Myocardial Infarction - Pinakin Parekh, Singapore
• EPIC-CAD - Edoxaban monotherapy vs. dual antithrombotic therapy for atrial fibrillation and stable coronary artery disease - Linda Lison, Indonesia

15:45 – 17:00 -  Improving care of patients with diabetes and cardiovascular disease – finding the sweet spot

Chairpersons: Michel Komajda, France (ESC) - Jude Erric Cinco, Philippines

Panelists: - Moncy Oommen, Brunei - Choong-Hou Koh, Singapore

• Key messages from the 2023 ESC Guidelines for the Management of Cardiovascular Disease in Patients with Diabetes - Michel Komajda, France (ESC)
• Screening of cardiovascular disease in asymptomatic diabetes mellitus patients - is there a role? - Soon-Wee Tiang, Malaysia
• Managing diabetes mellitus in patients with cardiovascular disease - targets, therapeutic agents - Wann-Jia Loh, Singapore
• Special considerations in managing cardiovascular disease in obese diabetes mellitus patients - Ade Meidian Ambari, Indonesia
• Panel discussion

The full AFFC programme is available under this link.

Registration

There will be no additional registration fees for the ESC in Asia with the AFC track. 

Register now

Venue

Shangri-la Singapore

22 Orange Grove Rd

Singapore

SG258350

Contact

If you have any questions, please send us an email at escasia@escardio.org

Other Events in Asia with the ESC in 2024 & 2025